Hepatitis B ESL Education for Chinese

关于北美华人的疾病预防行为知之甚少，相对较少的研究涉及这一群体的癌症控制。然而，华裔美国人/加拿大人的肝癌发病率比非拉丁裔白人高得多。这种过度风险归因于高B型肝炎病毒（HBV）感染率和低水平的B型肝炎疫苗接种覆盖率。亚洲和其他移民群体健康素养战略发展的一个关键领域是设计和评估文化上适当的英语作为第二语言（ESL）课程。我们研究的目标是增加接受HBV感染证据检测的中国成年人的比例。我们的目的是进行一项分组随机对照试验，以评估肝癌控制教育干预在中国参加ESL课程的可接受性，可行性和有效性。我们的研究将在华盛顿的西雅图和不列颠哥伦比亚省的温哥华进行。健康行为框架，从以前的B型肝炎定性研究的结果，以及ESL教师和学生的焦点小组将被用来制定B型肝炎教育计划。将以ESL班级作为随机化单位进行干预试验。60个ESL班将被随机分为实验组和对照组。600名年龄在18-64岁之间的中国男性和女性将参加试验。实验组将接受B型肝炎干预，对照组将接受心脏病干预。教育部分将包括ESL课程和小册子。参与者将在接受健康教育之前完成一项自我管理的基线调查。结局评价将基于亲自随访调查和医疗记录验证的数据。我们的主要结果将是HBV血清学检测。关于B型肝炎关键事实的知识将作为次要结局进行检查。

Little is known about the disease prevention behavior of Chinese in North America, and relatively few studies have addressed cancer control in this group. However, Chinese Americans/Canadians have a much higher incidence of liver cancer than non-Latino Whites. This excess risk is attributable to high rates of hepatitis B virus (HBV) infection combined with low levels of hepatitis B vaccination coverage. One critical area for the strategic development of health literacy among Asian and other immigrant groups is the design and evaluation of culturally appropriate English as a second language (ESL) curricula. The goal of our research is to increase the proportion of Chinese adults who have been tested for evidence of HBV infection. Our objective is to conduct a group-randomized controlled trial to evaluate the acceptability, feasibility, and effectiveness of a liver cancer control educational intervention for Chinese attending ESL classes. Our study will be conducted in Seattle, Washington and Vancouver, British Columbia. The Health Behavior Framework, findings from a previous hepatitis B qualitative study, and focus groups of ESL teachers as well as students will be used to develop the hepatitis B educational program. An intervention trial will be conducted with ESL classes as the unit of randomization. Sixty ESL classes will be randomized to experimental or control status. Six hundred Chinese men and women aged 18-64 years will participate in the trial. The experimental group will receive a hepatitis B intervention and the control group will receive a heart disease intervention. Educational components will include an ESL curriculum as well as a pamphlet. Participants will complete a self-administered baseline survey, just prior to receiving health education. Outcome evaluation will be based on data from an in-person follow-up survey and medical record verification. Our primary outcome will be HBV serologic testing. Knowledge about key hepatitis B facts will be examined as a secondary outcome.